{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:08:08Z","timestamp":1780524488401,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.092","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T05:01:31Z","timestamp":1305954091000},"page":"4739-4744","source":"Crossref","is-referenced-by-count":98,"title":["Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States"],"prefix":"10.1016","volume":"29","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Comanducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomira","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Schmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Muzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Hoiseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin U.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Messonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard W.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2011.04.092_bib0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.092_bib0010","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infection and Immunity"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2011.04.092_bib0015","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.vaccine.2005.01.056","article-title":"Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B","volume":"23","author":"Pillai","year":"2005","journal-title":"Vaccine"},{"issue":"5459","key":"10.1016\/j.vaccine.2011.04.092_bib0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science (New York, NY)"},{"issue":"29","key":"10.1016\/j.vaccine.2011.04.092_bib0025","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"21","key":"10.1016\/j.vaccine.2011.04.092_bib0030","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2011.04.092_bib0035","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1074\/jbc.C800214200","article-title":"Solution structure of the factor H-binding protein, a survival factor and protective antigen of Neisseria meningitidis","volume":"284","author":"Cantini","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.092_bib0040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"10.1016\/j.vaccine.2011.04.092_bib0045","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infection and Immunity"},{"issue":"10","key":"10.1016\/j.vaccine.2011.04.092_bib0050","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.vaccine.2008.12.052","article-title":"Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease","volume":"27","author":"Jacobsson","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2011.04.092_bib0055","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2005.11.006","article-title":"Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens","volume":"24","author":"Jacobsson","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.092_bib0060","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/JCM.00936-09","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales","volume":"47","author":"Lucidarme","year":"2009","journal-title":"Journal of Clinical Microbiology"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.092_bib0065","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"The Journal of Infectious Diseases"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.092_bib0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Molecular Microbiology"},{"issue":"Suppl. 8","key":"10.1016\/j.vaccine.2011.04.092_bib0075","doi-asserted-by":"crossref","first-page":"I46","DOI":"10.1016\/j.vaccine.2008.11.068","article-title":"Factor H-binding protein, a unique meningococcal vaccine antigen","volume":"26","author":"Pizza","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.092_bib0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.092_bib0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.092_bib0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"The Journal of Immunology"},{"issue":"12","key":"10.1016\/j.vaccine.2011.04.092_bib0095","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"The Journal of Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.092_bib0100","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0915162107","article-title":"Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans","volume":"107","author":"Serruto","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.092_bib0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/JCM.42.1.320-328.2004","article-title":"Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis","volume":"42","author":"Mothershed","year":"2004","journal-title":"Journal of Clinical Microbiology"},{"issue":"Web Server issue","key":"10.1016\/j.vaccine.2011.04.092_bib0110","doi-asserted-by":"crossref","first-page":"W606","DOI":"10.1093\/nar\/gkp288","article-title":"Meningococcus genome informatics platform: a system for analyzing multilocus sequence typing data","volume":"37","author":"Katz","year":"2009","journal-title":"Nucleic Acids Research"},{"issue":"16","key":"10.1016\/j.vaccine.2011.04.092_bib0115","first-page":"1493","article-title":"Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain","volume":"281","author":"Diermayer","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.vaccine.2011.04.092_bib0120","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"issue":"25\u20136","key":"10.1016\/j.vaccine.2011.04.092_bib0125","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.vaccine.2009.01.075","article-title":"Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide","volume":"27","author":"McNeil","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.092_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/14760584.8.2.135","article-title":"World vaccine congress","volume":"8","author":"Arora","year":"2009","journal-title":"Expert Reviews Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2011.04.092_bib0135","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.04.092_bib0140","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines","volume":"50","author":"Granoff","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.04.092_bib0145","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.092_bib0150","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.092_bib0155","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/651505","article-title":"Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era \u2013 United States, 2000\u20132005","volume":"201","author":"Harrison","year":"2010","journal-title":"The Journal of Infectious Diseases"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.092_bib0160","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/315833","article-title":"Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992\u20131998","volume":"182","author":"Sacchi","year":"2000","journal-title":"The Journal of Infectious Diseases"},{"issue":"10","key":"10.1016\/j.vaccine.2011.04.092_bib0165","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vaccine.2011.04.092_bib0170","unstructured":"CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 2005; 54(RR-7):1\u201321."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T18:58:17Z","timestamp":1543777097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11006475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":34,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11006475"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}